208 related articles for article (PubMed ID: 21568677)
1. Protease activity of the API2-MALT1 fusion oncoprotein in MALT lymphoma development and treatment.
Rosebeck S; Lucas PC; McAllister-Lucas LM
Future Oncol; 2011 May; 7(5):613-7. PubMed ID: 21568677
[TBL] [Abstract][Full Text] [Related]
2. Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma.
Hosokawa Y
Apoptosis; 2005 Jan; 10(1):25-34. PubMed ID: 15711920
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathogenesis of MALT lymphoma: two signaling pathways underlying the antiapoptotic effect of API2-MALT1 fusion protein.
Nakagawa M; Seto M; Hosokawa Y
Leukemia; 2006 Jun; 20(6):929-36. PubMed ID: 16572204
[TBL] [Abstract][Full Text] [Related]
4. API2-MALT1 oncoprotein promotes lymphomagenesis via unique program of substrate ubiquitination and proteolysis.
Rosebeck S; Lim MS; Elenitoba-Johnson KS; McAllister-Lucas LM; Lucas PC
World J Biol Chem; 2016 Feb; 7(1):128-37. PubMed ID: 26981201
[TBL] [Abstract][Full Text] [Related]
5. MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells.
Ho L; Davis RE; Conne B; Chappuis R; Berczy M; Mhawech P; Staudt LM; Schwaller J
Blood; 2005 Apr; 105(7):2891-9. PubMed ID: 15598810
[TBL] [Abstract][Full Text] [Related]
6. A Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-kappaB activation by API2middle dotMALT1 fusions.
Noels H; van Loo G; Hagens S; Broeckx V; Beyaert R; Marynen P; Baens M
J Biol Chem; 2007 Apr; 282(14):10180-9. PubMed ID: 17287209
[TBL] [Abstract][Full Text] [Related]
7. Selective expansion of marginal zone B cells in Emicro-API2-MALT1 mice is linked to enhanced IkappaB kinase gamma polyubiquitination.
Baens M; Fevery S; Sagaert X; Noels H; Hagens S; Broeckx V; Billiau AD; De Wolf-Peeters C; Marynen P
Cancer Res; 2006 May; 66(10):5270-7. PubMed ID: 16707452
[TBL] [Abstract][Full Text] [Related]
8. Oncogene-induced MALT1 protease activity drives posttranscriptional gene expression in malignant lymphomas.
Wimberger N; Ober F; Avar G; Grau M; Xu W; Lenz G; Menden MP; Krappmann D
Blood; 2023 Dec; 142(23):1985-2001. PubMed ID: 37623434
[TBL] [Abstract][Full Text] [Related]
9. The API2-MALT1 fusion exploits TNFR pathway-associated RIP1 ubiquitination to promote oncogenic NF-κB signaling.
Rosebeck S; Rehman AO; Apel IJ; Kohrt D; Appert A; O'Donnell MA; Ting AT; Du MQ; Baens M; Lucas PC; McAllister-Lucas LM
Oncogene; 2014 May; 33(19):2520-30. PubMed ID: 23770847
[TBL] [Abstract][Full Text] [Related]
10. Stability and subcellular localization of API2-MALT1 chimeric protein involved in t(11;18) (q21;q21) MALT lymphoma.
Izumiyama K; Nakagawa M; Yonezumi M; Kasugai Y; Suzuki R; Suzuki H; Tsuzuki S; Hosokawa Y; Asaka M; Seto M
Oncogene; 2003 Nov; 22(50):8085-92. PubMed ID: 14603249
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism.
Hamoudi RA; Appert A; Ye H; Ruskone-Fourmestraux A; Streubel B; Chott A; Raderer M; Gong L; Wlodarska I; De Wolf-Peeters C; MacLennan KA; de Leval L; Isaacson PG; Du MQ
Leukemia; 2010 Aug; 24(8):1487-97. PubMed ID: 20520640
[TBL] [Abstract][Full Text] [Related]
12. Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activation.
Rosebeck S; Madden L; Jin X; Gu S; Apel IJ; Appert A; Hamoudi RA; Noels H; Sagaert X; Van Loo P; Baens M; Du MQ; Lucas PC; McAllister-Lucas LM
Science; 2011 Jan; 331(6016):468-72. PubMed ID: 21273489
[TBL] [Abstract][Full Text] [Related]
13. Antiapoptotic function of apoptosis inhibitor 2-MALT1 fusion protein involved in t(11;18)(q21;q21) mucosa-associated lymphoid tissue lymphoma.
Hosokawa Y; Suzuki H; Suzuki Y; Takahashi R; Seto M
Cancer Res; 2004 May; 64(10):3452-7. PubMed ID: 15150097
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence of API2-MALT1 fusion gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas and diffuse large B cell lymphomas].
Li BZ; Lu HF; Sheng WQ; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):765-8. PubMed ID: 20079017
[TBL] [Abstract][Full Text] [Related]
15. Activation of NF-kappaB and inhibition of p53-mediated apoptosis by API2/mucosa-associated lymphoid tissue 1 fusions promote oncogenesis.
Stoffel A; Chaurushiya M; Singh B; Levine AJ
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9079-84. PubMed ID: 15184680
[TBL] [Abstract][Full Text] [Related]
16. Mucosa-associated lymphoid tissue lymphoma: molecular pathogenesis and clinicopathological significance.
Inagaki H
Pathol Int; 2007 Aug; 57(8):474-84. PubMed ID: 17610471
[TBL] [Abstract][Full Text] [Related]
17. API2-MALT1 fusion gene in colorectal lymphoma.
Sakugawa ST; Yoshino T; Nakamura S; Inagaki H; Sadahira Y; Nakamine H; Okabe M; Ichimura K; Tanimoto M; Akagi T
Mod Pathol; 2003 Dec; 16(12):1232-41. PubMed ID: 14681324
[TBL] [Abstract][Full Text] [Related]
18. Auto-ubiquitination-induced degradation of MALT1-API2 prevents BCL10 destabilization in t(11;18)(q21;q21)-positive MALT lymphoma.
Noels H; Somers R; Liu H; Ye H; Du MQ; De Wolf-Peeters C; Marynen P; Baens M
PLoS One; 2009; 4(3):e4822. PubMed ID: 19279678
[TBL] [Abstract][Full Text] [Related]
19. A dual role for the API2 moiety in API2-MALT1-dependent NF-kappaB activation: heterotypic oligomerization and TRAF2 recruitment.
Lucas PC; Kuffa P; Gu S; Kohrt D; Kim DS; Siu K; Jin X; Swenson J; McAllister-Lucas LM
Oncogene; 2007 Aug; 26(38):5643-54. PubMed ID: 17334391
[TBL] [Abstract][Full Text] [Related]
20. The API2/MALT1 fusion product may lead to germinal center B cell lymphomas by suppression of apoptosis.
Stoffel A; Le Beau MM
Hum Hered; 2001; 51(1-2):1-7. PubMed ID: 11096264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]